Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer
Clinical trial NCT02659514 · COMPLETED
Trial details
- NCT number
- NCT02659514
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2020-03-11
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.